International Linked Clinical Trials (iLCT)
28 results.
In 2025, VAI continued to build scientific momentum and drive discoveries that deepen our understanding of human health. With the addition of new faculty and…
GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials…
LONDON (Oct. 16, 2025) — The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched, led by…
Earlier this week, The Lancet published results of a phase 3 clinical trial that explored whether the Type 2 diabetes medication exenatide could…
The past year at Van Andel Institute can be summed up in two words: “growth” and “impact.”
We’ve expanded our research capacity by adding new…
In September, Van Andel Institute welcomed nearly 300 scientists, physicians and people with Parkinson’s for our annual Grand Challenges in Parkinson’s Disease symposium and Rallying…
LONDON (May 29, 2024) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce funding for…
LONDON (April 3, 2024) — Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may…